Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application (Oncology, Infectious Diseases), By Route Of Administration (Oral, Transdermal, Injectable), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Route of admission (RoA)
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interview in North America
    • 1.3.5.2. Data for primary interview in Europe
    • 1.3.5.3. Data for primary interview in Asia Pacific
    • 1.3.5.4. Data for primary interview in Latin America
    • 1.3.5.5. Data for primary interview in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Route of administration (RoA) outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Growing demand for novel drug delivery devices
    • 3.4.1.2. Increasing prevalence of chronic diseases
    • 3.4.1.3. Technological advancement in drug delivery devices
    • 3.4.1.4. Growing strategic alliances for drug delivery devices
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Challenges associated with various routes of drug delivery devices
  • 3.4.3. Industry challenges
• 3.5. Drug Delivery Devices Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Route of Administration (RoA) Estimates & Trend Analysis

• 4.1. Definition and Scope
  • 4.1.1. Oral
  • 4.1.2. Inhalation
  • 4.1.3. Transdermal
  • 4.1.4. Injectable
  • 4.1.5. Ocular
  • 4.1.6. Nasal
  • 4.1.7. Topical
  • 4.1.8. Others
• 4.2. RoA Market Share, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Drug Delivery Devices Market by RoA Outlook
• 4.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
  • 4.5.1. Oral
    • 4.5.1.1. Market estimates and forecast, by oral, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.2. Inhalation
    • 4.5.2.1. Market estimates and forecast, by inhalation, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.3. Transdermal
    • 4.5.3.1. Market estimates and forecast, by transdermal, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.4. Injectable
    • 4.5.4.1. Market estimates and forecast, by injectable, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.5. Ocular
    • 4.5.5.1. Market estimates and forecast, by ocular, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.6. Nasal
    • 4.5.6.1. Market estimates and forecast, by nasal, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.7. Topical
    • 4.5.7.1. Market estimates and forecast, by tropical, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.8. Others
    • 4.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 5. Application Estimates & Trend Analysis

• 5.1. Definition and Scope
  • 5.1.1. Oncology
  • 5.1.2. Infectious diseases
  • 5.1.3. Respiratory disease
  • 5.1.4. Diabetes
  • 5.1.5. Cardiovascular disease
  • 5.1.6. Autoimmune disease
  • 5.1.7. Central nervous system disorders
  • 5.1.8. Others
• 5.2. Application Market Share, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Drug Delivery Devices Market by Application Outlook
• 5.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
  • 5.5.1. Oncology
    • 5.5.1.1. Market estimates and forecast, by oncology, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.2. Infectious disease
    • 5.5.2.1. Market estimates and forecast, by infectious disease, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.3. Respiratory disease
    • 5.5.3.1. Market estimates and forecast, by respiratory disease, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.4. Diabetes
    • 5.5.4.1. Market estimates and forecast, by diabetes, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.5. Cardiovascular diseases
    • 5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.6. Autoimmune disease
    • 5.5.6.1. Market estimates and forecast, by autoimmune disease, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.7. Central nervous system disorders
    • 5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.8. Others
    • 5.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 6. End-use Estimates & Trend Analysis

• 6.1. Definition and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Diagnostic centers
  • 6.1.3. Ambulatory surgery centers/clinics
  • 6.1.4. Home care settings
  • 6.1.5. Others
• 6.2. End-use Market Share, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Drug Delivery Devices Market by End-use Outlook
• 6.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
  • 6.5.1. Hospital
    • 6.5.1.1. Market estimates and forecast, by hospital, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.2. Diagnostic centers
    • 6.5.2.1. Market estimates and forecast, by diagnostic centers, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.3. Ambulatory surgery centers/clinics
    • 6.5.3.1. Market estimates and forecast, by ambulatory surgery centers/clinics, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.4. Home care settings
    • 6.5.4.1. Market estimates and forecast, by home care settings, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.5. Others
    • 6.5.5.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2019
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East & Africa
• 7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East & Africa
• 7.6. Market Size & Forecast, Volume & Trend Analysis, 2018 to 2030
• 7.7. North America
  • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.2. U.S.
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement structure
    • 7.7.2.5. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.3. Canada
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement structure
    • 7.7.3.5. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.8. Europe
  • 7.8.1. UK
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement structure
    • 7.8.1.5. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.2. Germany
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement structure
    • 7.8.2.5. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.3. France
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement structure
    • 7.8.3.5. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.4. Italy
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement structure
    • 7.8.4.5. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.5. Spain
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement structure
    • 7.8.5.5. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.6. Denmark
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement structure
    • 7.8.6.5. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.7. Sweden
    • 7.8.7.1. Key country dynamics
    • 7.8.7.2. Competitive scenario
    • 7.8.7.3. Regulatory framework
    • 7.8.7.4. Reimbursement structure
    • 7.8.7.5. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.8. Norway
    • 7.8.8.1. Key country dynamics
    • 7.8.8.2. Competitive scenario
    • 7.8.8.3. Regulatory framework
    • 7.8.8.4. Reimbursement structure
    • 7.8.8.5. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.9. Asia Pacific
  • 7.9.1. Japan
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement structure
    • 7.9.1.5. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.2. China
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement structure
    • 7.9.2.5. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.3. India
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement structure
    • 7.9.3.5. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.4. Australia
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement structure
    • 7.9.4.5. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.5. South Korea
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Competitive scenario
    • 7.9.5.3. Regulatory framework
    • 7.9.5.4. Reimbursement structure
    • 7.9.5.5. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.6. Thailand
    • 7.9.6.1. Key country dynamics
    • 7.9.6.2. Competitive scenario
    • 7.9.6.3. Regulatory framework
    • 7.9.6.4. Reimbursement structure
    • 7.9.6.5. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.10. Latin America
  • 7.10.1. Brazil
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement structure
    • 7.10.1.5. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.10.2. Mexico
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement structure
    • 7.10.2.5. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.10.3. Argentina
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement structure
    • 7.10.3.5. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.11. MEA
  • 7.11.1. South Africa
    • 7.11.1.1. Key country dynamics
    • 7.11.1.2. Competitive scenario
    • 7.11.1.3. Regulatory framework
    • 7.11.1.4. Reimbursement structure
    • 7.11.1.5. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11.2. Saudi Arabia
    • 7.11.2.1. Key country dynamics
    • 7.11.2.2. Competitive scenario
    • 7.11.2.3. Regulatory framework
    • 7.11.2.4. Reimbursement structure
    • 7.11.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11.3. UAE
    • 7.11.3.1. Key country dynamics
    • 7.11.3.2. Competitive scenario
    • 7.11.3.3. Regulatory framework
    • 7.11.3.4. Reimbursement structure
    • 7.11.3.5. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11.4. Kuwait
    • 7.11.4.1. Key country dynamics
    • 7.11.4.2. Competitive scenario
    • 7.11.4.3. Regulatory framework
    • 7.11.4.4. Reimbursement structure
    • 7.11.4.5. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
  • 8.2.2. Market Lenders
  • 8.2.3. Emerging Players
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
• 8.4. Public Companies
  • 8.4.1. Company market position analysis (Revenue, geographic, presence, product portfolio, key serviceable industries, key alliance
  • 8.4.2. Company market share/ranking, by region
  • 8.4.3. Competitive dashboard analysis
    • 8.4.3.1. Market differentiators
    • 8.4.3.2. Synergy analysis: major deals and strategic alliances
• 8.5. Private Companies
  • 8.5.1. List of key emerging companies/technology disruptors/innovators
  • 8.5.2. Funding outlook
  • 8.5.3. Regional network map
  • 8.5.4. Company market position analysis (Geographic, presence, product portfolio, key alliance, industry experience)
• 8.6. Suppliers Ranking
• 8.7. Key Companies Profiled
  • 8.7.1. Pfizer, Inc,
    • 8.7.1.1. Company overview
    • 8.7.1.2. Financial performance
    • 8.7.1.3. Product benchmarking
    • 8.7.1.4. Strategic initiatives
  • 8.7.2. F. Hoffmann-La Roche Ltd.
    • 8.7.2.1. Company overview
    • 8.7.2.2. Financial performance
    • 8.7.2.3. Product benchmarking
    • 8.7.2.4. Strategic initiatives
  • 8.7.3. Johnson and Johnson Services
    • 8.7.3.1. Company overview
    • 8.7.3.2. Financial performance
    • 8.7.3.3. Product benchmarking
    • 8.7.3.4. Strategic initiatives
  • 8.7.4. Novartis AG
    • 8.7.4.1. Company overview
    • 8.7.4.2. Financial performance
    • 8.7.4.3. Product benchmarking
    • 8.7.4.4. Strategic initiatives
  • 8.7.5. Bayer AG
    • 8.7.5.1. Company overview
    • 8.7.5.2. Financial performance
    • 8.7.5.3. Product benchmarking
    • 8.7.5.4. Strategic initiatives
  • 8.7.6. BD
    • 8.7.6.1. Company overview
    • 8.7.6.2. Financial performance
    • 8.7.6.3. Product benchmarking
    • 8.7.6.4. Strategic initiatives
  • 8.7.7. Uniqure N.V.
    • 8.7.7.1. Company overview
    • 8.7.7.2. Financial performance
    • 8.7.7.3. Product benchmarking
    • 8.7.7.4. Strategic initiatives
  • 8.7.8. SiBiono GeneTech Co.
    • 8.7.8.1. Company overview
    • 8.7.8.2. Financial performance
    • 8.7.8.3. Product benchmarking
    • 8.7.8.4. Strategic initiatives
  • 8.7.9. Shanghai Sunway Biotech Co., Ltd
    • 8.7.9.1. Company overview
    • 8.7.9.2. Financial performance
    • 8.7.9.3. Product benchmarking
    • 8.7.9.4. Strategic initiatives
  • 8.7.10. Human Stem Cells Institute
    • 8.7.10.1. Company overview
    • 8.7.10.2. Financial performance
    • 8.7.10.3. Product benchmarking
    • 8.7.10.4. Strategic initiatives

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
• Table 3 North America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 4 North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 5 North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 6 U.S. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 7 U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 8 U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 9 Canada drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 10 Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 11 Canada drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 12 Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 13 Europe drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 14 Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 15 Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 16 Germany drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 17 Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 18 Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 19 U.K. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 20 U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 21 U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 22 France drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 23 France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 24 France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 25 Italy drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 26 Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 27 Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 28 Spain drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 29 Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 30 Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 31 Denmark drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 32 Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 33 Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 34 Sweden drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 35 Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 36 Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 37 Norway drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 38 Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 39 Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 40 APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 41 APAC drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 42 APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 43 APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 44 China drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 45 China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 46 China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 47 Japan drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 48 Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 49 Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 50 India drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 51 India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 52 India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 53 Thailand drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 54 Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 55 Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 56 South Korea drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 57 South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 58 South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 59 Australia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 60 Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 61 Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 62 Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 63 Latin America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 64 Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 65 Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 66 Brazil drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 67 Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 68 Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 69 Mexico drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 70 Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 71 Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 72 Argentina drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 73 Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 74 Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 75 Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 76 Middle East and Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 77 Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 78 Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 79 South Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 80 South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 81 South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 82 Saudi Arabia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 83 Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 84 Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 85 UAE drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 86 UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 87 UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 88 Kuwait drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 89 Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 90 Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Drug delivery devices: market outlook
• Fig. 14 Drug delivery devices market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook.
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Drug delivery devices market driver impact
• Fig. 20 Drug delivery devices market restraint impact
• Fig. 21 Drug delivery devices market strategic initiatives analysis
• Fig. 22 Drug delivery devices market: RoA movement analysis
• Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
• Fig. 24 Oral market estimates and forecast, 2018 - 2030
• Fig. 25 Inhalation market estimates and forecast, 2018 - 2030
• Fig. 26 Transdermal market estimates and forecast, 2018 - 2030
• Fig. 27 Injectable market estimates and forecast, 2018 - 2030
• Fig. 28 Ocular market estimates and forecast, 2018 - 2030
• Fig. 29 Nasal market estimates and forecast, 2018 - 2030
• Fig. 30 Topical market estimates and forecast, 2018 - 2030
• Fig. 31 Others market estimates and forecast, 2018 - 2030
• Fig. 32 Drug delivery devices market: application movement analysis
• Fig. 33 Drug delivery devices market: application outlook and key takeaways
• Fig. 34 Oncology market estimates and forecast, 2018 - 2030
• Fig. 35 Infectious diseases estimates and forecast, 2018 - 2030
• Fig. 36 Respiratory diseases estimates and forecast, 2018 - 2030
• Fig. 37 Diabetes estimates and forecast, 2018 - 2030
• Fig. 38 Cardiovascular diseases estimates and forecast, 2018 - 2030
• Fig. 39 Autoimmune diseases estimates and forecast, 2018 - 2030
• Fig. 40 Central nervous system disorders estimates and forecast, 2018 - 2030
• Fig. 41 Others estimates and forecast, 2018 - 2030
• Fig. 42 Drug delivery devices market: end-use movement analysis
• Fig. 43 Drug delivery devices market: End-use outlook and key takeaways
• Fig. 44 Hospitals estimates and forecast, 2018 - 2030
• Fig. 45 Diagnostic centers estimates and forecast, 2018 - 2030
• Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2018 - 2030
• Fig. 47 Home care setting estimates and forecast, 2018 - 2030
• Fig. 48 Others estimates and forecast, 2018 - 2030
• Fig. 49 Global drug delivery devices market: regional movement analysis
• Fig. 50 Global drug delivery market: regional outlook and key takeaways
• Fig. 51 Global market share and leading players
• Fig. 52 North America market share and leading players
• Fig. 53 Europe market share and leading players
• Fig. 54 Asia Pacific market share and leading players
• Fig. 55 Latin America market share and leading players
• Fig. 56 Middle East & Africa market share and leading players
• Fig. 57 North America: SWOT
• Fig. 58 Europe SWOT
• Fig. 59 Asia Pacific SWOT
• Fig. 60 Latin America SWOT
• Fig. 61 MEA SWOT
• Fig. 62 North America, by country
• Fig. 63 North America
• Fig. 64 North America market estimates and forecast, 2018 - 2030
• Fig. 65 U.S.
• Fig. 66 U.S. market estimates and forecast, 2018 - 2030
• Fig. 67 Canada
• Fig. 68 Canada market estimates and forecast, 2018 - 2030
• Fig. 69 Europe
• Fig. 70 Europe. market estimates and forecast, 2018 - 2030
• Fig. 71 UK
• Fig. 72 UK market estimates and forecast, 2018 - 2030
• Fig. 73 Germany
• Fig. 74 Germany market estimates and forecast, 2018 - 2030
• Fig. 75 France
• Fig. 76 France market estimates and forecast, 2018 - 2030
• Fig. 77 Italy
• Fig. 78 Italy market estimates and forecast, 2018 - 2030
• Fig. 79 Spain
• Fig. 80 Spain market estimates and forecast, 2018 - 2030
• Fig. 81 Denmark
• Fig. 82 Denmark market estimates and forecast, 2018 - 2030
• Fig. 83 Sweden
• Fig. 84 Sweden market estimates and forecast, 2018 - 2030
• Fig. 85 Norway
• Fig. 86 Norway market estimates and forecast, 2018 - 2030
• Fig. 87 Asia Pacific
• Fig. 88 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 89 China
• Fig. 90 China market estimates and forecast, 2018 - 2030
• Fig. 91 Japan
• Fig. 92 Japan market estimates and forecast, 2018 - 2030
• Fig. 93 India
• Fig. 94 India market estimates and forecast, 2018 - 2030
• Fig. 95 Thailand
• Fig. 96 Thailand. market estimates and forecast, 2018 - 2030
• Fig. 97 South Korea
• Fig. 98 South Korea market estimates and forecast, 2018 - 2030
• Fig. 99 Australia
• Fig. 100 Australia market estimates and forecast, 2018 - 2030
• Fig. 101 Latin America
• Fig. 102 Latin America market estimates and forecast, 2018 - 2030
• Fig. 103 Brazil
• Fig. 104 Brazil market estimates and forecast, 2018 - 2030
• Fig. 105 Mexico
• Fig. 106 Mexico market estimates and forecast, 2018 - 2030
• Fig. 107 Argentina
• Fig. 108 Argentina market estimates and forecast, 2018 - 2030
• Fig. 109 Middle East and Africa
• Fig. 110 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 111 South Africa
• Fig. 112 South Africa market estimates and forecast, 2018 - 2030
• Fig. 113 Saudi Arabia
• Fig. 114 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 115 UAE
• Fig. 116 UAE market estimates and forecast, 2018 - 2030
• Fig. 117 Kuwait
• Fig. 118 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 119 Participant categorization- drug delivery devices market
• Fig. 120 Market share of key market players- drug delivery devices market